The Division of Pediatric Neuroendocrinology was established in 2008 through the merger of the Pediatric Neurology and Pediatric Endocrinology specialties. It is distinguished by its integrated approach to diagnosing and treating neurological and endocrine disorders and holds significant influence in both the pediatric neurology and endocrinology fields in China.
The Pediatric Neurology specialty is one of the earliest neurology specialties established in the Guangzhou region. It has developed into a member unit of both the Brain Science Professional Committee and the Developmental and Behavioral Pediatrics Committee of the Pediatrics Society of the Chinese Medical Association. It also serves as the chair unit of the Child Development and Rehabilitation Branch of the Guangdong Rehabilitation Medicine Association, the chair unit of the Developmental and Behavioral Pediatrics Branch of the Guangdong Brain Development and Brain Disease Prevention and Treatment Society, and the vice-chair unit of the Neurology Group under the Pediatrics Society of the Guangdong Medical Association, exerting considerable influence in South China and nationwide. The specialty offers neuroelectrophysiological examinations, neuroimaging studies, intelligence testing, developmental assessments, psychological evaluations, and motor assessments. It provides drug therapy and psychological counseling for children with neurological, psychological, and psychiatric conditions, and offers motor, psychological, and speech rehabilitation for children with special needs. The department has accumulated extensive experience in the diagnosis, treatment, and research of conditions such as pediatric epilepsy, cerebral palsy, autism spectrum disorder, movement disorders, myopathies, attention deficit hyperactivity disorder (ADHD), tic disorders, multiple sclerosis, and other immune-mediated encephalitides. Since pioneering clinical research on high-dose intravenous immunoglobulin therapy for multiple sclerosis in China in 1996, the department has gained rich experience and achieved favorable outcomes in treating pediatric neuroimmune disorders. Utilizing advanced MRI technology for pathological classification of encephalopathies combined with flow cytometry for immune phenotyping enables the implementation of tailored treatment plans, significantly improving therapeutic efficacy for conditions like encephalitis and cerebral palsy. The Autism BTR Strategy pioneered by the department has substantially enhanced clinical outcomes and improved the prognosis for autism. Leveraging the strong technical capabilities of the hospital's Department of Hematology, the department has initiated clinical research on bone marrow transplantation for treating adrenoleukodystrophy and progressive muscular dystrophy, offering hope for managing these previously incurable conditions.
The Pediatric Endocrinology and Inherited Metabolic Diseases specialty is one of the earliest in Guangdong and South China to focus on the diagnosis, treatment, and research of pediatric endocrine and metabolic disorders. It possesses extensive experience in treating conditions such as short stature, precocious puberty, congenital adrenal hyperplasia, diabetes, obesity, metabolic syndrome, thyroid disorders, bone metabolism abnormalities, diabetes insipidus, multiple pituitary hormone deficiencies, disorders of sex development, and endocrine tumors, actively promoting standardized diagnosis and treatment for pediatric endocrine diseases. The department pioneered the use of new technologies in the Guangdong region, such as microarray comparative genomic hybridization and next-generation sequencing for etiological research in pediatric neurodevelopmental disorders and rare diseases in children, and has participated in formulating several national industry guidelines. The department offers a comprehensive range of diagnostic tests, including assays for growth hormone, gonadotropin axis hormones, thyroid hormones, and glucose metabolism-related endocrine hormones; various dynamic function tests for diagnosing endocrine disorders; and AI-assisted bone age assessment and height prediction. Relying on national key laboratories, its test results are accurate and reliable. The department is a member unit of the Pediatric Endocrinology and Inherited Metabolic Diseases Group of the Pediatrics Society of the Chinese Medical Association and the vice-chair unit of the Pediatric Endocrinology and Inherited Metabolic Diseases Group of the Guangdong Medical Association.
The Division of Pediatric Neuroendocrinology currently has 2 senior professional titles, 4 associate senior professional titles, 1 doctoral supervisor, 5 master's supervisors, and nearly 30 medical technical staff. The current department director is Professor Luo Xiangyang (Neurology specialty), and the deputy director is Professor Liang Liyang (Endocrinology and Inherited Metabolic Diseases specialty).
